BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2017;12:825-835. [PMID: 27821390 DOI: 10.2215/cjn.05780616] [Cited by in Crossref: 291] [Cited by in F6Publishing: 137] [Article Influence: 48.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhai X, Zhang Y, Xin S, Cao P, Lu J. Insights Into the Involvement of Circular RNAs in Autoimmune Diseases. Front Immunol 2021;12:622316. [PMID: 33717126 DOI: 10.3389/fimmu.2021.622316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wan Z, Pascual V. Breaching self-tolerance by targeting the gatekeeper. J Exp Med 2021;218:e20210322. [PMID: 33847707 DOI: 10.1084/jem.20210322] [Reference Citation Analysis]
3 Singh S, Sreenidhi HC. Prognostic value of modified National Institute of Health activity and chronicity scoring in determining complete renal response in newly diagnosed lupus nephritis: a retrospective single centre study. Int Urol Nephrol. [DOI: 10.1007/s11255-022-03112-9] [Reference Citation Analysis]
4 Zhang M, Jie H, Wu Y, Han X, Li X, He Y, Shi X, Luo Y, Sun Y, Yang J, Yang J, Quan S, Lao X, Tan L, Sun E. Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity. Arthritis Res Ther 2020;22:239. [PMID: 33054864 DOI: 10.1186/s13075-020-02332-7] [Reference Citation Analysis]
5 Aly R, Zeng X, Acharya R, Upadhyay K. Delayed Onset Minimal Change Disease as a Manifestation of Lupus Podocytopathy. Clin Pract 2021;11:747-54. [PMID: 34698110 DOI: 10.3390/clinpract11040089] [Reference Citation Analysis]
6 Kim J, Lee JS, Go H, Lim JS, Oh JS, Kim YG, Lee CK, Yoo B, Hong S. Clinical and histological significance of urinary CD11c+ macrophages in lupus nephritis. Arthritis Res Ther 2020;22:173. [PMID: 32680578 DOI: 10.1186/s13075-020-02265-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Scobell R, Pradhan M. Management of Lupus Nephritis in Children. Indian Pediatr 2020;57:401-6. [DOI: 10.1007/s13312-020-1811-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Obrișcă B, Sorohan B, Tuță L, Ismail G. Advances in Lupus Nephritis Pathogenesis: From Bench to Bedside. Int J Mol Sci 2021;22:3766. [PMID: 33916456 DOI: 10.3390/ijms22073766] [Reference Citation Analysis]
9 Gergianaki I, Bertsias G. Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. Front Med (Lausanne) 2018;5:161. [PMID: 29896474 DOI: 10.3389/fmed.2018.00161] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
10 Xia J, Cao W. Epigenetic modifications of Klotho expression in kidney diseases. J Mol Med (Berl) 2021;99:581-92. [PMID: 33547909 DOI: 10.1007/s00109-021-02044-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Vahedi-Mazdabadi Y, Saeedi M. Treatment of Lupus Nephritis from Iranian Traditional Medicine and Modern Medicine Points of View: A Comparative Study. Evid Based Complement Alternat Med 2021;2021:6645319. [PMID: 34795786 DOI: 10.1155/2021/6645319] [Reference Citation Analysis]
12 Wise LM, Stohl W. Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents. Front Med (Lausanne) 2020;7:303. [PMID: 32695790 DOI: 10.3389/fmed.2020.00303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
13 Kim CS, Mathew AP, Vasukutty A, Uthaman S, Joo SY, Bae EH, Ma SK, Park IK, Kim SW. Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis. J Nanobiotechnology 2021;19:109. [PMID: 33865397 DOI: 10.1186/s12951-021-00857-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Khairallah MK, Makarem YS, Dahpy MA. Vitamin D in active systemic lupus erythematosus and lupus nephritis: a forgotten player. Egypt J Intern Med 2020;32. [DOI: 10.1186/s43162-020-00016-x] [Reference Citation Analysis]
15 Pan J, Wang X, Cang X, Jiang Y, Tang R. Hsa_circ_0010957 knockdown attenuates lipopolysaccharide-induced HK2 cell injury by regulating the miR-1224-5p/IRAK1 axis. Cent Eur J Immunol 2021;46:314-24. [PMID: 34764803 DOI: 10.5114/ceji.2021.108772] [Reference Citation Analysis]
16 Chalmers SA, Ayilam Ramachandran R, Garcia SJ, Der E, Herlitz L, Ampudia J, Chu D, Jordan N, Zhang T, Parodis I, Gunnarsson I, Ding H, Shen N, Petri M, Mok CC, Saxena R, Polu KR, Connelly S, Ng CT, Mohan C, Putterman C. The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses. J Clin Invest 2022;132:e147334. [PMID: 34981775 DOI: 10.1172/JCI147334] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A; World Kidney Day Steering Committee. What we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on World Kidney Day and International Woman's Day. BMC Nephrol 2018;19:66. [PMID: 29544451 DOI: 10.1186/s12882-018-0864-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
18 Kang Y, Yan Q, Fu Q, Wang R, Dai M, Du F, Dai Q, Ye P, Wu C, Lu L, Bao C. Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study. Arthritis Res Ther 2020;22:65. [PMID: 32228698 DOI: 10.1186/s13075-020-02154-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Maria NI, Davidson A. Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy. Nat Rev Rheumatol 2020;16:255-67. [PMID: 32203285 DOI: 10.1038/s41584-020-0401-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
20 Udompornpitak K, Bhunyakarnjanarat T, Charoensappakit A, Dang CP, Saisorn W, Leelahavanichkul A. Lipopolysaccharide-Enhanced Responses against Aryl Hydrocarbon Receptor in FcgRIIb-Deficient Macrophages, a Profound Impact of an Environmental Toxin on a Lupus-Like Mouse Model. Int J Mol Sci 2021;22:4199. [PMID: 33919603 DOI: 10.3390/ijms22084199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Chen T, Cao Q, Wang R, Zheng G, Azmi F, Wang J, Lee VW, Wang YM, Yu H, Patel M, P'ng CH, Alexander SI, Rogers NM, Wang Y, Harris DCH. Conventional Type 1 Dendritic Cells (cDC1) in Human Kidney Diseases: Clinico-Pathological Correlations. Front Immunol 2021;12:635212. [PMID: 34054804 DOI: 10.3389/fimmu.2021.635212] [Reference Citation Analysis]
22 Essouma M, Nkeck JR, Motolouze K, Bigna JJ, Tchaptchet P, Nkoro GA, Ralandison S, Hachulla E. Outcomes of pregnancy and associated factors in sub-Saharan African women with systemic lupus erythematosus: a scoping review. Lupus Sci Med 2020;7:e000400. [PMID: 32540928 DOI: 10.1136/lupus-2020-000400] [Reference Citation Analysis]
23 Caster DJ, Powell DW. Utilization of Biomarkers in Lupus Nephritis. Adv Chronic Kidney Dis 2019;26:351-9. [PMID: 31733719 DOI: 10.1053/j.ackd.2019.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
24 Kong W, Wang Y, Wang H, Zhou Q, Chen J, Han F. Systemic sclerosis complicated with renal thrombotic microangiopathy: a case report and literature review. BMC Nephrol 2022;23:22. [PMID: 35012481 DOI: 10.1186/s12882-021-02639-w] [Reference Citation Analysis]
25 Tanaka Y, Hoshino-Negishi K, Kuboi Y, Tago F, Yasuda N, Imai T. Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases. Immunotargets Ther 2020;9:241-53. [PMID: 33178636 DOI: 10.2147/ITT.S277991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
26 Kelleher C, Kocinsky H. Novel Complement Therapeutics in Development as Potential Treatment for Renal Disease. Adv Chronic Kidney Dis 2020;27:95-103. [PMID: 32553251 DOI: 10.1053/j.ackd.2020.02.006] [Reference Citation Analysis]
27 Yang P, Zhang X, Chen S, Tao Y, Ning M, Zhu Y, Liang J, Kong W, Shi B, Li Z, Shen H, Wang Y. A Novel Serum tsRNA for Diagnosis and Prediction of Nephritis in SLE. Front Immunol 2021;12:735105. [PMID: 34867955 DOI: 10.3389/fimmu.2021.735105] [Reference Citation Analysis]
28 Ma Y, Fang L, Zhang R, Zhao P, Li Y, Li R. Cyclophosphamide Attenuates Fibrosis in Lupus Nephritis by Regulating Mesangial Cell Cycle Progression. Dis Markers 2021;2021:3803601. [PMID: 34820026 DOI: 10.1155/2021/3803601] [Reference Citation Analysis]
29 Zheng J, Guo R, Tang Y, Fu Q, Chen J, Wu L, Leng L, Bucala R, Song Y, Lu L. miR-152 Attenuates the Severity of Lupus Nephritis Through the Downregulation of Macrophage Migration Inhibitory Factor (MIF)-Induced Expression of COL1A1. Front Immunol 2019;10:158. [PMID: 30787934 DOI: 10.3389/fimmu.2019.00158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
30 Lee MH, Koh JWH, Ng CH, Lim SHH, Cho J, Lateef A, Mak A, Tay SH. A meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender. Semin Arthritis Rheum 2021:S0049-0172(21)00216-X. [PMID: 34996626 DOI: 10.1016/j.semarthrit.2021.12.004] [Reference Citation Analysis]
31 Vollbach K, Schuetz C, Hedrich CM, Speth F, Mönkemöller K, Brunner J, Neudorf U, Rietschel C, Hospach A, Kallinich T, Hinze C, Wagner N, Tönshoff B, Weber LT, Latta K, Thumfart J, Bald M, Wiemann D, Zappel H, Tenbrock K, Haffner D. Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis – A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria. Front Pediatr 2022;10:851998. [DOI: 10.3389/fped.2022.851998] [Reference Citation Analysis]
32 An N, Yang C, Wu HL, Guo Y, Huang XJ, Huang TS, Wu ZH, Xue J, Chen RH, Li ZH, Pan QJ, Liu HF. Hydroxychloroquine administration exacerbates acute kidney injury complicated by lupus nephritis. Arthritis Res Ther 2022;24:6. [PMID: 34980245 DOI: 10.1186/s13075-021-02700-x] [Reference Citation Analysis]
33 Hachiya A, Karasawa M, Imaizumi T, Kato N, Katsuno T, Ishimoto T, Kosugi T, Tsuboi N, Maruyama S. The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis. Sci Rep 2021;11:1525. [PMID: 33452282 DOI: 10.1038/s41598-020-78972-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mohandas R, Douma LG, Scindia Y, Gumz ML. Circadian rhythms and renal pathophysiology. J Clin Invest 2022;132:e148277. [PMID: 35104800 DOI: 10.1172/JCI148277] [Reference Citation Analysis]
35 Pirson V, Enfrein A, Houssiau FA, Tamirou F. Absence of renal remission portends poor long-term kidney outcome in lupus nephritis. Lupus Sci Med 2021;8:e000533. [PMID: 34446568 DOI: 10.1136/lupus-2021-000533] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Yip TC, Saria S, Petri M, Magder LS. Predictors of the start of declining eGFR in patients with systemic lupus erythematosus. Lupus 2021;30:15-24. [PMID: 33115373 DOI: 10.1177/0961203320966393] [Reference Citation Analysis]
37 Gasparotto M, Gatto M, Binda V, Doria A, Moroni G. Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology (Oxford) 2020;59:v39-51. [PMID: 33280015 DOI: 10.1093/rheumatology/keaa381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
38 Jorge A, Wallace ZS, Zhang Y, Lu N, Costenbader KH, Choi HK. All-Cause and Cause-Specific Mortality Trends of End-Stage Renal Disease Due to Lupus Nephritis From 1995 to 2014. Arthritis Rheumatol 2019;71:403-10. [PMID: 30225916 DOI: 10.1002/art.40729] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
39 Choi EW, Song JW, Ha N, Choi YI, Kim S. CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus. Sci Rep 2018;8:17297. [PMID: 30470828 DOI: 10.1038/s41598-018-35602-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
40 Schrezenmeier E, Jayne D, Dörner T. Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives. J Am Soc Nephrol 2018;29:741-58. [PMID: 29326157 DOI: 10.1681/ASN.2017040367] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
41 Santo BA, Segal BH, Tomaszewski JE, Mohammad I, Worral AM, Jain S, Visser MB, Sarder P. Neutrophil Extracellular Traps (NETs): An unexplored territory in renal pathobiology, a pilot computational study. Proc SPIE Int Soc Opt Eng 2020;11320:1132012. [PMID: 32377029 DOI: 10.1117/12.2549340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Ahn SS, Yoo J, Jung SM, Song JJ, Park YB, Lee SW. Comparison of the Clinical Implications among Five Different Nutritional Indices in Patients with Lupus Nephritis. Nutrients 2019;11:E1456. [PMID: 31252552 DOI: 10.3390/nu11071456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Limesh M, Kedlaya PG, Renuka S, Vinod N. Long-term Outcome of Lupus Nephritis: A Single Center Study. Indian J Nephrol 2021;31:225-9. [PMID: 34376934 DOI: 10.4103/ijn.IJN_25_20] [Reference Citation Analysis]
44 Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A. What We Do and Do Not Know about Women and Kidney Diseases; Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Women's Day. Kidney Dis (Basel) 2018;4:37-48. [PMID: 29594141 DOI: 10.1159/000485269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Kraaij T, Arends EJ, van Dam LS, Kamerling SWA, van Daele PLA, Bredewold OW, Ray A, Bakker JA, Scherer HU, Huizinga TJW, Rabelink TJ, van Kooten C, Teng YKO. Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results. Nephrol Dial Transplant 2021;36:1474-83. [PMID: 32591783 DOI: 10.1093/ndt/gfaa117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
46 Liu L, Wang R, Ding H, Tian L, Gao T, Bao C. The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients. PLoS One 2020;15:e0240942. [PMID: 33108403 DOI: 10.1371/journal.pone.0240942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Farr L, Ghosh S, Moonah S. Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair. Front Immunol 2020;11:1273. [PMID: 32655566 DOI: 10.3389/fimmu.2020.01273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
48 Almaani S, Bhatt U, Arriens C, Bonfa E, Dall'Era M, Houssiau F, Kalunian K, Mackay M, Sanchez-Guerrero J, Solomons N, Rovin BH. Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints. Kidney Int Rep 2020;5:1302-5. [PMID: 32775830 DOI: 10.1016/j.ekir.2020.05.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Leatherwood C, Speyer CB, Feldman CH, D'Silva K, Gómez-Puerta JA, Hoover PJ, Waikar SS, McMahon GM, Rennke HG, Costenbader KH. Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies. Semin Arthritis Rheum 2019;49:396-404. [PMID: 31277928 DOI: 10.1016/j.semarthrit.2019.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
50 Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A; World Kidney Day Steering Committee. Women and Kidney Diseases: Questions Unanswered and Answers Unquestioned. Kidney Int Rep 2018;3:225-35. [PMID: 29725625 DOI: 10.1016/j.ekir.2018.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
51 Mahto H, Tripathy R, Meher BR, Prusty BK, Sharma M, Deogharia D, Saha AK, Panda AK, Das BK. TNF-α promoter polymorphisms (G-238A and G-308A) are associated with susceptibility to Systemic Lupus Erythematosus (SLE) and P. falciparum malaria: a study in malaria endemic area. Sci Rep 2019;9:11752. [PMID: 31409832 DOI: 10.1038/s41598-019-48182-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
52 Ryu S, Lee EY, Kim DK, Kim YS, Chung DH, Kim JH, Lee H, Kim HY. Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis. Arthritis Res Ther 2020;22:63. [PMID: 32223753 DOI: 10.1186/s13075-020-2114-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Wang L, Lin W, Chen J. Krüppel-like Factor 15: A Potential Therapeutic Target For Kidney Disease. Int J Biol Sci 2019;15:1955-61. [PMID: 31523196 DOI: 10.7150/ijbs.34838] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Foster MH, Ord JR. Emerging immunotherapies for autoimmune kidney disease. Hum Vaccin Immunother 2019;15:876-90. [PMID: 30550361 DOI: 10.1080/21645515.2018.1555569] [Reference Citation Analysis]
55 Namba T, Ichii O, Nakamura T, Masum MA, Otani Y, Hosotani M, Elewa YHA, Kon Y. Compartmentalization of interleukin 36 subfamily according to inducible and constitutive expression in the kidneys of a murine autoimmune nephritis model. Cell Tissue Res 2021. [PMID: 34287716 DOI: 10.1007/s00441-021-03495-8] [Reference Citation Analysis]
56 Luan J, Jiao C, Kong W, Fu J, Qu W, Chen Y, Zhu X, Zeng Y, Guo G, Qi H, Yao L, Pi J, Wang L, Zhou H. circHLA-C Plays an Important Role in Lupus Nephritis by Sponging miR-150. Mol Ther Nucleic Acids 2018;10:245-53. [PMID: 29499937 DOI: 10.1016/j.omtn.2017.12.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
57 Farah RI, Dannoun E, Abu Shahin N, AlRyalat SA. Characteristics and Histological Types of Lupus Nephritis in a Jordanian Tertiary Medical Center. Biomed Res Int 2019;2019:7087461. [PMID: 31019971 DOI: 10.1155/2019/7087461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Nicolaou O, Sokratous K, Makowska Z, Morell M, De Groof A, Montigny P, Hadjisavvas A, Michailidou K, Oulas A, Spyrou GM, Demetriou C, Alarcón-Riquelme ME, Psarellis S, Kousios A, Lauwerys B, Kyriacou K. Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis. Arthritis Res Ther 2020;22:147. [PMID: 32552896 DOI: 10.1186/s13075-020-02236-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Pires JR, Nogueira MRS, Nunes AJF, Degand DRF, Pessoa LC, Damante CA, Zangrando MSR, Greghi SLA, de Rezende MLR, Sant'Ana ACP. Deposition of Immune Complexes in Gingival Tissues in the Presence of Periodontitis and Systemic Lupus Erythematosus. Front Immunol 2021;12:591236. [PMID: 33841392 DOI: 10.3389/fimmu.2021.591236] [Reference Citation Analysis]
60 Sakhi H, Moktefi A, Bouachi K, Audard V, Hénique C, Remy P, Ollero M, El Karoui K. Podocyte Injury in Lupus Nephritis. J Clin Med 2019;8:E1340. [PMID: 31470591 DOI: 10.3390/jcm8091340] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
61 Sharma J, Larkin J 3rd. Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer. Front Pharmacol 2019;10:324. [PMID: 31105556 DOI: 10.3389/fphar.2019.00324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
62 Hsieh TY, Lin YC, Hung WT, Chen YM, Wen MC, Chen HH, Lin WY, Hsieh CW, Lin CT, Lai KL, Tang KT, Tseng CW, Huang WN, Chen YH, Tsai SC, Wu YD. Change of Renal Gallium Uptake Correlated with Change of Inflammation Activity in Renal Pathology in Lupus Nephritis Patients. J Clin Med 2021;10:4654. [PMID: 34682781 DOI: 10.3390/jcm10204654] [Reference Citation Analysis]
63 Martin M, Trattner R, Nilsson SC, Björk A, Zickert A, Blom AM, Gunnarsson I. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients. Front Immunol 2020;11:582737. [PMID: 33133102 DOI: 10.3389/fimmu.2020.582737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
64 Liu YC, Chun J. Prospects for Precision Medicine in Glomerulonephritis Treatment. Can J Kidney Health Dis 2018;5:2054358117753617. [PMID: 29449955 DOI: 10.1177/2054358117753617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
65 Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A. What We Do and Do Not Know About Women and Kidney Diseases; Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Woman's Day. Can J Kidney Health Dis 2018;5:2054358118761656. [PMID: 29552348 DOI: 10.1177/2054358118761656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Ravindran A, Casal Moura M, Fervenza FC, Nasr SH, Alexander MP, Fidler ME, Herrera Hernandez LP, Zhang P, Grande JP, Cornell LD, Gross LA, Negron V, Jenson GE, Madden BJ, Charlesworth MC, Sethi S. In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes. J Am Soc Nephrol 2021;32:695-706. [PMID: 33478971 DOI: 10.1681/ASN.2020081181] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
67 Hu YC, Tsai IJ, Hsu HY, Chiang BL, Yang YH. Identification of monoclonal antibodies against human renal glomerular endothelial cells in lupus nephritis that induce endothelial interferon-alpha production. Arthritis Res Ther 2021;23:171. [PMID: 34134755 DOI: 10.1186/s13075-021-02552-5] [Reference Citation Analysis]
68 Stein MC, Braun F, Krebs CF, Bunders MJ. Kidney organoid systems for studies of immune-mediated kidney diseases: challenges and opportunities. Cell Tissue Res 2021. [PMID: 34309728 DOI: 10.1007/s00441-021-03499-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Shater H, Fawzy M, Farid A, El-Amir A, Fouad S, Madbouly N. The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family. Lupus 2022;:9612033211063794. [PMID: 34978958 DOI: 10.1177/09612033211063794] [Reference Citation Analysis]
70 Yu J, Xie D, Huang N, Zhou Q. Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease. Front Med (Lausanne) 2021;8:714958. [PMID: 34604256 DOI: 10.3389/fmed.2021.714958] [Reference Citation Analysis]
71 Gao Y, Wang B, Cao J, Feng S, Liu B. Elevated Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Biomarker for Lupus Nephritis: A Systematic Review and Meta-Analysis. Biomed Res Int 2020;2020:2768326. [PMID: 32685458 DOI: 10.1155/2020/2768326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Li K, Yu Y, Gao Y, Zhao F, Liang Z, Gao J. Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis. Front Immunol 2022;13:859380. [DOI: 10.3389/fimmu.2022.859380] [Reference Citation Analysis]
73 Tseng TC, Huang DY, Lai LC, Hwai H, Hsiao YW, Jhou JP, Chuang EY, Tzeng SJ. Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1. J Mol Med (Berl) 2018;96:413-25. [PMID: 29508016 DOI: 10.1007/s00109-018-1626-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Mao Z, Tan Y, Yu F, Zhao M. Discovery of NEU1 as a candidatedone. renal biomarker for proliferative lupus nephritis chronicity. Lupus Sci Med 2021;8:e000569. [PMID: 34872988 DOI: 10.1136/lupus-2021-000569] [Reference Citation Analysis]
75 Jia NY, Liu XZ, Zhang Z, Zhang H. Weighted Gene Co-expression Network Analysis Reveals Different Immunity but Shared Renal Pathology Between IgA Nephropathy and Lupus Nephritis. Front Genet 2021;12:634171. [PMID: 33854525 DOI: 10.3389/fgene.2021.634171] [Reference Citation Analysis]
76 Wang J, Chen Q, Zhang Z, Wang S, Wang Y, Xiang M, Liang J, Xu J. Azithromycin alleviates systemic lupus erythematosus via the promotion of M2 polarisation in lupus mice. Cell Death Discov 2021;7:82. [PMID: 33863874 DOI: 10.1038/s41420-021-00466-4] [Reference Citation Analysis]
77 Chen XT, Li ZW, Zhao X, Li ML, Hou PF, Chu SF, Zheng JN, Bai J. Role of Circular RNA in Kidney-Related Diseases. Front Pharmacol 2021;12:615882. [PMID: 33776764 DOI: 10.3389/fphar.2021.615882] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 El-Mohsen MA, Tawfik A, Bichari W, Shawky S, Mady G, Hassan M. Value of Urinary Neutrophil Gelatinase-Associated Lipocalin versus Conventional Biomarkers in Predicting Response to Treatment of Active Lupus Nephritis. Int J Nephrol 2020;2020:8855614. [PMID: 33083057 DOI: 10.1155/2020/8855614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Edavalath S, Rai MK, Gupta V, Mishra R, Misra DP, Gupta L, Agarwal V. Tacrolimus induces remission in refractory and relapsing lupus nephritis by decreasing P-glycoprotein expression and function on peripheral blood lymphocytes. Rheumatol Int 2022. [PMID: 34993577 DOI: 10.1007/s00296-021-05057-1] [Reference Citation Analysis]
80 Wang F, Yu J, Zhang L, Zhang Y, Zhang J, Liu B, Yang X. Clinical relevance of glomerular IgM deposition in patients with lupus nephritis. BMC Immunol 2021;22:75. [PMID: 34876020 DOI: 10.1186/s12865-021-00467-z] [Reference Citation Analysis]
81 Jiang MY, Hwang JC, Feng IJ. Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus. Sci Rep 2018;8:6008. [PMID: 29662119 DOI: 10.1038/s41598-018-24529-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
82 Ke B, Chen Y, Tu W, Ye T, Fang X, Yang L. Inhibition of HDAC6 activity in kidney diseases: a new perspective. Mol Med 2018;24:33. [PMID: 30134806 DOI: 10.1186/s10020-018-0027-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
83 Siddiqui RS, Sumbly V, Abrudescu A. A Case of Rapidly Proliferative Glomerulonephritis Secondary to Syphilis That Responded to Treatment With Penicillin. Cureus 2021;13:e13468. [PMID: 33777557 DOI: 10.7759/cureus.13468] [Reference Citation Analysis]
84 Yordanov M, Rushidova F, Hrincheva M, Ananiev J. A Case of Lupus Nephritis Aggravated by Diabetic Nephropathy with a Rapid Decline in Kidney Function. Acta Medica Bulgarica 2021;48:72-5. [DOI: 10.2478/amb-2021-0026] [Reference Citation Analysis]
85 Kong J, Li L, Lu Z, Song J, Yan J, Yang J, Gu Z, Da Z. MicroRNA-155 Suppresses Mesangial Cell Proliferation and TGF-β1 Production via Inhibiting CXCR5-ERK Signaling Pathway in Lupus Nephritis. Inflammation 2019;42:255-63. [PMID: 30209639 DOI: 10.1007/s10753-018-0889-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
86 Watson D, Yang JYC, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Louie V, Sigdel S, Livingstone D, Soh K, Chakraborty A, Liang M, Lin PC, Sarwal MM. A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury. J Clin Med 2019;8:E499. [PMID: 31013714 DOI: 10.3390/jcm8040499] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
87 Kwon OC, Park JH, Park HC, Jung SM, Lee SW, Song JJ, Park YB, Park MC. Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis. Arthritis Res Ther 2020;22:138. [PMID: 32517774 DOI: 10.1186/s13075-020-02223-x] [Reference Citation Analysis]
88 Wang L, Wang Q, Bai H, Liu C, Liu W, Zhang Y, Jiang L, Xu H, Wang K, Zhou Y. EHR2Vec: Representation Learning of Medical Concepts From Temporal Patterns of Clinical Notes Based on Self-Attention Mechanism. Front Genet 2020;11:630. [PMID: 32714371 DOI: 10.3389/fgene.2020.00630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Skopelja-Gardner S, Colonna L, Hermanson P, Sun X, Tanaka L, Tai J, Nguyen Y, Snyder JM, Alpers CE, Hudkins KL, Salant DJ, Peng Y, Elkon KB. Complement Deficiencies Result in Surrogate Pathways of Complement Activation in Novel Polygenic Lupus-like Models of Kidney Injury. J Immunol 2020;204:2627-40. [PMID: 32238460 DOI: 10.4049/jimmunol.1901473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lande R, Palazzo R, Gestermann N, Jandus C, Falchi M, Spadaro F, Riccieri V, James EA, Butera A, Boirivant M, Feldmeyer L, Surbeck I, Di Lucca J, Stuber F, Spinelli FR, Botti E, Marinari B, Bianchi L, Pica R, Cerbelli B, Giannakakis K, Auteri SE, Daniels I, Durrant LG, Horstman S, Costanzo A, Romero P, Alessandri C, Conti F, Valesini G, Gilliet M, Chizzolini C, Frasca L. Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus. Sci Rep 2020;10:5851. [PMID: 32245990 DOI: 10.1038/s41598-020-62480-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
91 Udupa V, Keepanasseril A, Vijayan N, Basu D, Negi VS. Early Onset Pre-Eclampsia with Nephrotic Range Proteinuria as the Initial Manifestation of Lupus Nephritis: Report of three cases. Sultan Qaboos Univ Med J 2019;19:e73-6. [PMID: 31198600 DOI: 10.18295/squmj.2019.19.01.014] [Reference Citation Analysis]
92 Razek AAKA, Khalek AMA, Tharwat S, Nassar MK, Tharwat N. Diffusion tensor imaging of renal cortex in lupus nephritis. Jpn J Radiol 2021. [PMID: 34125367 DOI: 10.1007/s11604-021-01154-0] [Reference Citation Analysis]
93 Gai L, Zhu Y, Zhang C, Meng X. Targeting Canonical and Non-Canonical STAT Signaling Pathways in Renal Diseases. Cells 2021;10:1610. [PMID: 34199002 DOI: 10.3390/cells10071610] [Reference Citation Analysis]
94 Jebakumar D, Jones KA. Educational Case: Antiglomerular Basement Membrane Disease as an Example of Antibody-Mediated Glomerulonephritis. Acad Pathol 2020;7:2374289520911185. [PMID: 32284964 DOI: 10.1177/2374289520911185] [Reference Citation Analysis]
95 Dong X, Zheng Z, Luo X, Ding J, Li Y, Li Z, Li S, Rong M, Fu Y, Wu Z, Zhu P. Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study. Medicine (Baltimore) 2018;97:e0343. [PMID: 29668584 DOI: 10.1097/MD.0000000000010343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
96 Blomgren P, Chandrasekhar J, Di Paolo JA, Fung W, Geng G, Ip C, Jones R, Kropf JE, Lansdon EB, Lee S, Lo JR, Mitchell SA, Murray B, Pohlmeyer C, Schmitt A, Suekawa-Pirrone K, Wise S, Xiong JM, Xu J, Yu H, Zhao Z, Currie KS. Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases. ACS Med Chem Lett 2020;11:506-13. [PMID: 32292557 DOI: 10.1021/acsmedchemlett.9b00621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
97 Mertowski S, Lipa P, Morawska I, Niedźwiedzka-Rystwej P, Bębnowska D, Hrynkiewicz R, Grywalska E, Roliński J, Załuska W. Toll-Like Receptor as a Potential Biomarker in Renal Diseases. Int J Mol Sci 2020;21:E6712. [PMID: 32933213 DOI: 10.3390/ijms21186712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
98 Yang H, Li H. CD36 identified by weighted gene co-expression network analysis as a hub candidate gene in lupus nephritis. PeerJ 2019;7:e7722. [PMID: 31592160 DOI: 10.7717/peerj.7722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
99 Ren J, Liao X, Vieson MD, Chen M, Scott R, Kazmierczak J, Luo XM, Reilly CM. Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses. Clin Exp Immunol 2018;191:19-31. [PMID: 28876451 DOI: 10.1111/cei.13046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
100 Zhang S, Li M, Zhang L, Wang Z, Wang Q, You H, Wang Y, Li M, Zeng X. Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China. J Immunol Res 2021;2021:1349042. [PMID: 33532504 DOI: 10.1155/2021/1349042] [Reference Citation Analysis]
101 Dai Z, Zhang X, Wong IO, Lau EH, Lin Z. Treatment for Severe Lupus Nephritis: A Cost-Effectiveness Analysis in China. Front Pharmacol 2021;12:678301. [PMID: 34552479 DOI: 10.3389/fphar.2021.678301] [Reference Citation Analysis]
102 Cooley I, Derebail VK, Gibson KL, Álvarez C, Poulton CJ, Blazek LN, Love A, Hogan SL, Jennette JC, Falk RJ, Sheikh SZ; Chapel Hill Alliance Promoting Excellence in Lupus (CHAPEL) group of investigators. Association of Lupus Nephritis Histopathologic Classification With Venous Thromboembolism-Modification by Age at Biopsy. Kidney Int Rep 2021;6:1653-60. [PMID: 34169206 DOI: 10.1016/j.ekir.2021.02.015] [Reference Citation Analysis]
103 Zheng Z, Zhang H, Peng X, Zhang C, Xing C, Xu G, Fu P, Ni Z, Chen J, Xu Z, Zhao MH, Li S, Huang X, Miao L, Chen X, Liu B, He Y, Li J, Liu L, Kadeerbai H, Liu Z, Liu Z. Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial. JAMA Netw Open 2022;5:e224492. [PMID: 35353167 DOI: 10.1001/jamanetworkopen.2022.4492] [Reference Citation Analysis]
104 Yada N, Yoshimoto K, Kawashima H, Yoneima R, Nishimura N, Tai Y, Tsushima E, Miyamoto M, Ono S, Matsumoto M, Fujimoto T, Nishio K. Plasma Level of von Willebrand Factor Propeptide at Diagnosis: A Marker of Subsequent Renal Dysfunction in Autoimmune Rheumatic Diseases. Clin Appl Thromb Hemost 2020;26:1076029620938874. [PMID: 32705883 DOI: 10.1177/1076029620938874] [Reference Citation Analysis]
105 Reid S, Alexsson A, Frodlund M, Morris D, Sandling JK, Bolin K, Svenungsson E, Jönsen A, Bengtsson C, Gunnarsson I, Illescas Rodriguez V, Bengtsson A, Arve S, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Sjöwall C, Vyse TJ, Rönnblom L, Leonard D. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. Ann Rheum Dis 2020;79:363-9. [PMID: 31826855 DOI: 10.1136/annrheumdis-2019-216227] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
106 Cody EM, Bennett MR, Gulati G, Ma Q, Altaye M, Devarajan P, Brunner HI. Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity. Kidney Int Rep 2021;6:1949-60. [PMID: 34307989 DOI: 10.1016/j.ekir.2021.04.016] [Reference Citation Analysis]
107 Oliva-Damaso N, Bomback AS. Belimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for Therapeutics. Am J Kidney Dis 2021;77:984-7. [PMID: 33221369 DOI: 10.1053/j.ajkd.2020.11.003] [Reference Citation Analysis]
108 Wang M, Liang Y, Hu Z, Chen S, Shi B, Heidari AA, Zhang Q, Chen H, Chen X. Lupus nephritis diagnosis using enhanced moth flame algorithm with support vector machines. Comput Biol Med 2022;145:105435. [PMID: 35397339 DOI: 10.1016/j.compbiomed.2022.105435] [Reference Citation Analysis]
109 Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice. Front Immunol 2021;12:584414. [PMID: 33717066 DOI: 10.3389/fimmu.2021.584414] [Reference Citation Analysis]
110 Khan SQ, Khan I, Gupta V. CD11b Activity Modulates Pathogenesis of Lupus Nephritis. Front Med (Lausanne) 2018;5:52. [PMID: 29600248 DOI: 10.3389/fmed.2018.00052] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
111 Huang T, Li J, Zhang W. Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism. BMC Med Res Methodol 2020;20:99. [PMID: 32357838 DOI: 10.1186/s12874-020-00989-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Wu D, Ai L, Sun Y, Yang B, Chen S, Wang Q, Kuang H. Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals. Front Pharmacol 2021;12:621300. [PMID: 34489689 DOI: 10.3389/fphar.2021.621300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
113 Bertolo M, Baumgart S, Durek P, Peddinghaus A, Mei H, Rose T, Enghard P, Grützkau A. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis. Front Immunol 2020;11:256. [PMID: 32265898 DOI: 10.3389/fimmu.2020.00256] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
114 Putterman C. Lupus Nephritis: Persistent Challenges, New Approaches. Clin Immunol 2017;185:1-2. [PMID: 29150089 DOI: 10.1016/j.clim.2017.05.005] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
115 Villanueva V, Li X, Jimenez V, Faridi H, Gupta V. CD11b agonists offer a novel approach for treating lupus nephritis. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.03.001] [Reference Citation Analysis]
116 Pohlmeyer CW, Shang C, Han P, Cui ZH, Jones RM, Clarke AS, Murray BP, Lopez DA, Newstrom DW, Inzunza MD, Matzkies FG, Currie KS, Di Paolo JA. Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis. BMC Rheumatol 2021;5:15. [PMID: 33781343 DOI: 10.1186/s41927-021-00178-3] [Reference Citation Analysis]
117 Hashmi AA, Ali J, Rahman M, Taseer AR, Kumar J, Irfan M. Spectrum of Morphologic Features of Lupus Nephritis According to Nephrology/Renal Pathology Society (ISN/RPS) Classification. Cureus 2020;12:e10520. [PMID: 33094061 DOI: 10.7759/cureus.10520] [Reference Citation Analysis]
118 Bhargava R, Lehoux S, Maeda K, Tsokos MG, Krishfield S, Ellezian L, Pollak M, Stillman IE, Cummings RD, Tsokos GC. Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis. JCI Insight 2021;6:147789. [PMID: 33784256 DOI: 10.1172/jci.insight.147789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A; World Kidney Day Steering Committee. What We Do and Do Not Know about Women and Kidney Diseases: Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Women's Day. Indian J Nephrol 2018;28:87-96. [PMID: 29861556 DOI: 10.4103/ijn.IJN_81_18] [Reference Citation Analysis]
120 Jorge A, Wallace ZS, Lu N, Zhang Y, Choi HK. Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study. Ann Intern Med 2019;170:240-7. [PMID: 30665236 DOI: 10.7326/M18-1570] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 6.7] [Reference Citation Analysis]
121 Yang C, Wu M, You M, Chen Y, Luo M, Chen Q. The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases. Stem Cell Res Ther 2021;12:103. [PMID: 33541422 DOI: 10.1186/s13287-021-02158-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
122 Brady MP, Korte EA, Caster DJ, Powell DW. TNIP1/ABIN1 and lupus nephritis: review. Lupus Sci Med 2020;7:e000437. [PMID: 33122334 DOI: 10.1136/lupus-2020-000437] [Reference Citation Analysis]
123 Lodi L, Mastrolia MV, Bello F, Rossi GM, Angelotti ML, Crow YJ, Romagnani P, Vaglio A. Type I interferon-related kidney disorders. Kidney Int 2022:S0085-2538(22)00213-7. [PMID: 35339535 DOI: 10.1016/j.kint.2022.02.031] [Reference Citation Analysis]
124 Aljaberi N, Bennett M, Brunner HI, Devarajan P. Proteomic profiling of urine: implications for lupus nephritis. Expert Rev Proteomics 2019;16:303-13. [PMID: 30855196 DOI: 10.1080/14789450.2019.1592681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
125 Fu W, Liu Y, Liu F, Liu C, Li J, Niu J, Han P, Xu D, Hou J, Ma Y, Feng J, Li Z, Mu R, Yang G. A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis. Front Immunol 2021;12:656090. [PMID: 33841441 DOI: 10.3389/fimmu.2021.656090] [Reference Citation Analysis]
126 Ren J, Panther E, Liao X, Grammer AC, Lipsky PE, Reilly CM. The Impact of Protein Acetylation/Deacetylation on Systemic Lupus Erythematosus. Int J Mol Sci 2018;19:E4007. [PMID: 30545086 DOI: 10.3390/ijms19124007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
127 Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, Stallone G, Castellano G, Gesualdo L. Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention. Front Med (Lausanne) 2020;7:582272. [PMID: 33738291 DOI: 10.3389/fmed.2020.582272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Shen L, Lan L, Zhu T, Chen H, Gu H, Wang C, Chen Y, Wang M, Tu H, Enghard P, Jiang H, Chen J. Identification and Validation of IFI44 as Key Biomarker in Lupus Nephritis. Front Med (Lausanne) 2021;8:762848. [PMID: 34760904 DOI: 10.3389/fmed.2021.762848] [Reference Citation Analysis]
129 Nguyen Thi N, Tran Minh D, Nguyen Thu H, Luong Thi P, Thai Thien N, Pho Hong D, Nguyen Trung K, Tran Viet T, Do Q, Le Viet T. Association Between Hypoalbuminemia, Degree of Proteinuria, and Lupus Nephritis Class: A Single-Center Cross-sectional Biopsy Study. Nephro-Urol Mon 2021;13. [DOI: 10.5812/numonthly.112883] [Reference Citation Analysis]
130 Rekvig OP. Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis. Front Immunol 2020;11:569234. [PMID: 33123142 DOI: 10.3389/fimmu.2020.569234] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Russell DA, Markiewicz M, Oates JC. Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells. Lupus Sci Med 2020;7:e000418. [PMID: 33037079 DOI: 10.1136/lupus-2020-000418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
132 Ma HY, Chen S, Du Y. Estrogen and estrogen receptors in kidney diseases. Ren Fail 2021;43:619-42. [PMID: 33784950 DOI: 10.1080/0886022X.2021.1901739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
133 Tan Y, Yu F, Long J, Gan L, Wang H, Zhang L, Zhao M. Frequency of Systemic Lupus Erythematosus Was Decreasing Among Hospitalized Patients From 2013 to 2017 in a National Database in China. Front Med (Lausanne) 2021;8:648727. [PMID: 33889586 DOI: 10.3389/fmed.2021.648727] [Reference Citation Analysis]
134 Zhang C, Ge C, Wang J, Sun D. Fish oil enhanced the efficacy of low-dose cyclophosphamide regimen for proliferative lupus nephritis: a randomized controlled double-blind trial. Food Nutr Res 2021;65. [PMID: 34393696 DOI: 10.29219/fnr.v65.7842] [Reference Citation Analysis]
135 De Azevêdo Silva J, de Lima SC, Fragoso TS, Cavalcanti CAJ, Barbosa AD, Borborema MEA, de Lucena TMC, Duarte ALBP, Crovella S, Sandrin-Garcia P. Differential distribution of vitamin D receptor (VDR) gene variants and its expression in systemic lupus erythematosus. Int J Immunogenet 2022. [PMID: 35560516 DOI: 10.1111/iji.12576] [Reference Citation Analysis]
136 Mu Q, Cabana-Puig X, Mao J, Swartwout B, Abdelhamid L, Cecere TE, Wang H, Reilly CM, Luo XM. Pregnancy and lactation interfere with the response of autoimmunity to modulation of gut microbiota. Microbiome 2019;7:105. [PMID: 31311609 DOI: 10.1186/s40168-019-0720-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
137 Yan Q, Du F, Kang Y, Ye P, Wang X, Xu J, Tang J, Wang N, Jiang G, Li Z, Wang X, Xue Q, Huang X, Zhang X, Zhou Y, Dai M, Bao C. Comparison of iguratimod and conventional cyclophosphamide with sequential azathioprine as treatment of active lupus nephritis: study protocol for a multi-center, randomized, controlled clinical trial (iGeLU study). Trials 2021;22:530. [PMID: 34380536 DOI: 10.1186/s13063-021-05475-3] [Reference Citation Analysis]
138 Matusik PS, Łoboda P, Krzanowska K, Popiela TJ, Heba G, Pawlik W. Presence of retained calcified fibrin sheath after central venous catheter removal: A systematic literature review. J Vasc Access 2020;:1129729820969328. [PMID: 33143527 DOI: 10.1177/1129729820969328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Cadet MJ, Tucker L. Managing lupus nephritis: A guide for nurse practitioners. Nurse Pract 2018;43:43-8. [PMID: 30134437 DOI: 10.1097/01.NPR.0000544280.27880.fe] [Reference Citation Analysis]
140 Xu B, Zhang YM, Yang YW, Liu YS, Feng JF. Diagnostic performance of serum cystatin C and complement component 1q in lupus nephritis. Arthritis Res Ther 2019;21:267. [PMID: 31801580 DOI: 10.1186/s13075-019-2065-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Ubara Y, Kawaguchi T, Nagasawa T, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Tsuruya K; Committee of Practical Guide for Kidney Biopsy 2020. Kidney biopsy guidebook 2020 in Japan. Clin Exp Nephrol 2021;25:325-64. [PMID: 33606126 DOI: 10.1007/s10157-020-01986-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, Caricchio R, Buyon JP, Alekseyenko AV, Silverman GJ. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis 2019;78:947-56. [PMID: 30782585 DOI: 10.1136/annrheumdis-2018-214856] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 30.7] [Reference Citation Analysis]
143 Solé C, Moliné T, Vidal M, Ordi-Ros J, Cortés-Hernández J. An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis. Cells 2019;8:E773. [PMID: 31349698 DOI: 10.3390/cells8080773] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
144 Morris G, Athan E, Walder K, Bortolasci CC, O'Neil A, Marx W, Berk M, Carvalho AF, Maes M, Puri BK. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19? Life Sci 2020;262:118541. [PMID: 33035581 DOI: 10.1016/j.lfs.2020.118541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
145 Schreiber J, Eisenberger U, de Groot K. [Lupus nephritis]. Internist (Berl) 2019;60:468-77. [PMID: 30840107 DOI: 10.1007/s00108-019-0574-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
146 Salama AD, Caplin B. Lupus Nephritis and Chronic Kidney Disease. J Rheumatol 2020;47:1303-4. [PMID: 32873662 DOI: 10.3899/jrheum.200566] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Mysore V, Tahir S, Furuhashi K, Arora J, Rosetti F, Cullere X, Yazbeck P, Sekulic M, Lemieux ME, Raychaudhuri S, Horwitz BH, Mayadas TN. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. Journal of Experimental Medicine 2022;219:e20210562. [DOI: 10.1084/jem.20210562] [Reference Citation Analysis]
148 Mahajan A, Amelio J, Gairy K, Kaur G, Levy RA, Roth D, Bass D. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus 2020;29:1011-20. [PMID: 32571142 DOI: 10.1177/0961203320932219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
149 Patel AM, Karam LAR, Rojas SCF, Redfearn WE, Truong LD, Gonzalez JM. Rapidly Progressive Glomerulonephritis Secondary to IgA Nephropathy in a Patient with Systemic Lupus Erythematosus. Case Rep Nephrol 2019;2019:8354823. [PMID: 30956828 DOI: 10.1155/2019/8354823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Davies JC, Carlsson E, Midgley A, Smith EMD, Bruce IN, Beresford MW, Hedrich CM; BILAG-BR and MRC MASTERPLANS Consortia. A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment. Rheumatology (Oxford) 2021;60:3747-59. [PMID: 33313921 DOI: 10.1093/rheumatology/keaa851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Tonsawan P, Sawanyawisuth K. Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy. Auto Immun Highlights 2020;11:18. [PMID: 33261666 DOI: 10.1186/s13317-020-00140-2] [Reference Citation Analysis]
152 Caza TN, Hassen SI, Kuperman M, Sharma SG, Dvanajscak Z, Arthur J, Edmondson R, Storey A, Herzog C, Kenan DJ, Larsen CP. Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney Int 2021;100:171-81. [PMID: 33045259 DOI: 10.1016/j.kint.2020.09.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
153 Koopman JJE, Rennke HG, Leatherwood C, Speyer CB, D'Silva K, McMahon GM, Waikar SS, Costenbader KH. Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis. Rheumatology (Oxford) 2020;59:3751-8. [PMID: 32413140 DOI: 10.1093/rheumatology/keaa174] [Reference Citation Analysis]
154 Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A; World Kidney Day Steering Committee. What we do and do not know about women and kidney diseases: Questions unanswered and answers unquestioned : Reflection on World Kidney Day and International Woman's Day. Pediatr Nephrol 2018;33:529-40. [PMID: 29497823 DOI: 10.1007/s00467-018-3917-3] [Reference Citation Analysis]
155 Yao H, Deng Y, Du G, Wang Y, Tang G. Elevated mean platelet volume in oral lichen planus and increased blood urea nitrogen level in its red-form: an observational study. BMC Oral Health 2021;21:310. [PMID: 34134686 DOI: 10.1186/s12903-021-01659-0] [Reference Citation Analysis]
156 Cohen PL, Shao WH. Gas6/TAM Receptors in Systemic Lupus Erythematosus. Dis Markers 2019;2019:7838195. [PMID: 31360267 DOI: 10.1155/2019/7838195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
157 Gharbia OM, Bassiouni SAR, Zaki MES, El-beah SM, El-desoky MM, Elmansoury EA, Abdelsalam M. Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients. Egypt Rheumatol Rehabil 2021;48. [DOI: 10.1186/s43166-021-00093-y] [Reference Citation Analysis]
158 Liao X, Ren J, Reihl A, Pirapakaran T, Sreekumar B, Cecere TE, Reilly CM, Luo XM. Renal-infiltrating CD11c+ cells are pathogenic in murine lupus nephritis through promoting CD4+ T cell responses. Clin Exp Immunol 2017;190:187-200. [PMID: 28722110 DOI: 10.1111/cei.13017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
159 Abdelnabi HH. Is podocytopathy another image of renal affection in p-SLE? Pediatr Rheumatol Online J 2021;19:57. [PMID: 33902643 DOI: 10.1186/s12969-021-00547-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
160 Wlazlo E, Mehrad B, Morel L, Scindia Y. Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis. Front Med (Lausanne) 2021;8:643686. [PMID: 33912577 DOI: 10.3389/fmed.2021.643686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Nicola AA, Dună M, Miler I, Petre N, Predeţeanu D. Sysyemic Lupus Erythematosus with Multiple Organ Damage. Internal Medicine 2020;17:63-73. [DOI: 10.2478/inmed-2020-0135] [Reference Citation Analysis]
162 Suzuki E, Yashiro-Furuya M, Temmoku J, Fujita Y, Matsuoka N, Hazama M, Asano T, Sato S, Kobayashi H, Watanabe H, Kanno T, Migita K. Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis. Int J Rheum Dis 2021;24:1500-9. [PMID: 34636151 DOI: 10.1111/1756-185X.14228] [Reference Citation Analysis]
163 Lum PT, Sekar M, Gan SH, Jeyabalan S, Bonam SR, Rani NNIM, Ku-mahdzir K, Seow LJ, Wu YS, Subramaniyan V, Fuloria NK, Fuloria S. Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: A review. Saudi Journal of Biological Sciences 2022;29:1530-42. [DOI: 10.1016/j.sjbs.2021.11.016] [Reference Citation Analysis]
164 Ding X, Ren Y, He X. IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis. Front Immunol 2021;12:676082. [PMID: 33959133 DOI: 10.3389/fimmu.2021.676082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
165 Vanood A, Owen R, Maraskine M, Schreiber A, Pokharel R, Cohen L. Collapsing FSGS with Concurrent Class 2 and 3 Lupus Nephritis: A Case Report and Review of the Literature. Case Rep Nephrol Dial 2021;11:16-25. [PMID: 33708796 DOI: 10.1159/000510840] [Reference Citation Analysis]
166 Yang B, Hou S, Zhao J, Li Y. 3-hydroxy butyrate dehydrogenase 2 deficiency aggravates systemic lupus erythematosus progression in a mouse model by promoting CD40 ligand demethylation. Bioengineered 2022;13:2685-95. [PMID: 35001849 DOI: 10.1080/21655979.2022.2025694] [Reference Citation Analysis]
167 Rovin BH, Furie R, Teng YKO, Contreras G, Malvar A, Yu X, Ji B, Green Y, Gonzalez-Rivera T, Bass D, Gilbride J, Tang CH, Roth DA. A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis. Kidney Int 2021:S0085-2538(21)00862-0. [PMID: 34560137 DOI: 10.1016/j.kint.2021.08.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Xu ZQ, Ding Y, Huang XY, Xiang W, He XJ. CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I Signaling. Inflammation 2021. [PMID: 34091806 DOI: 10.1007/s10753-021-01487-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Tang S, Yu Q, Ding C. Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases. Expert Opin Investig Drugs 2022. [PMID: 35130124 DOI: 10.1080/13543784.2022.2040014] [Reference Citation Analysis]
170 Ma HY, Chen S, Cao WD, Min CT. Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Ren Fail 2021;43:20-31. [PMID: 33307926 DOI: 10.1080/0886022X.2020.1853568] [Reference Citation Analysis]
171 Bartels-Peculis L, Sharma A, Edwards AM, Sanyal A, Connolly-Strong E, Nelson WW. Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population. Open Access Rheumatol 2020;12:117-24. [PMID: 32607019 DOI: 10.2147/OARRR.S248750] [Reference Citation Analysis]
172 Herrada AA, Escobedo N, Iruretagoyena M, Valenzuela RA, Burgos PI, Cuitino L, Llanos C. Innate Immune Cells' Contribution to Systemic Lupus Erythematosus. Front Immunol 2019;10:772. [PMID: 31037070 DOI: 10.3389/fimmu.2019.00772] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
173 Zhang L, Zhang K, Dong W, Li R, Huang R, Zhang H, Shi W, Liu S, Li Z, Chen Y, Ye Z, Liang X, Yu X. Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide. Kidney Dis (Basel) 2020;6:355-63. [PMID: 33490115 DOI: 10.1159/000509767] [Reference Citation Analysis]
174 Xiong ZH, Cao XS, Guan HL, Zheng HL. Immunotherapies application in active stage of systemic lupus erythematosus in pregnancy: A case report and review of literature. World J Clin Cases 2020; 8(24): 6396-6407 [PMID: 33392323 DOI: 10.12998/wjcc.v8.i24.6396] [Reference Citation Analysis]
175 Ding H, Lin C, Cai J, Guo Q, Dai M, Mohan C, Shen N. Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology. Arthritis Res Ther 2020;22:122. [PMID: 32460901 DOI: 10.1186/s13075-020-02209-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
176 Jin J, Sun H, Shi C, Yang H, Wu Y, Li W, Dong YH, Cai L, Meng XM. Circular RNA in renal diseases. J Cell Mol Med 2020;24:6523-33. [PMID: 32333642 DOI: 10.1111/jcmm.15295] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
177 Parikh SV, Malvar A, Shapiro J, Turman JM, Song H, Alberton V, Lococo B, Mejia-Vilet JM, Madhavan S, Zhang J, Yu L, Satoskar AA, Birmingham D, Jarjour WN, Rovin BH, Ganesan LP. A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis. Front Immunol 2021;12:621039. [PMID: 33659005 DOI: 10.3389/fimmu.2021.621039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
178 Nnodum B, Dudley L. Class IV Lupus Nephritis in the Setting of Serologically Quiescent Disease and Normal Urine Sediment in a Patient with Late-Onset Systemic Lupus Erythematosus. Case Rep Rheumatol 2019;2019:1219529. [PMID: 30911427 DOI: 10.1155/2019/1219529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
179 Luan J, Fu J, Chen C, Jiao C, Kong W, Zhang Y, Chang Q, Wang Y, Li D, Illei GG, Kopp JB, Pi J, Zhou H. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration. Arthritis Res Ther 2019;21:276. [PMID: 31829247 DOI: 10.1186/s13075-019-2044-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
180 Piranavan P, Perl A. Management of cardiovascular disease in patients with systemic lupus erythematosus. Expert Opin Pharmacother 2020;21:1617-28. [PMID: 32511034 DOI: 10.1080/14656566.2020.1770227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Pinheiro SVB, Dias RF, Fabiano RCG, Araujo SA, Silva ACSE. Pediatric lupus nephritis. J Bras Nefrol 2019;41:252-65. [PMID: 30465590 DOI: 10.1590/2175-8239-JBN-2018-0097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
182 Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A; World Kidney Day Steering Committee. What we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on World Kidney Day and International Women's Day. J Nephrol 2018;31:173-84. [PMID: 29464527 DOI: 10.1007/s40620-018-0474-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
183 Aguirre-Valencia D, Ríos-Serna LJ, Posso-Osorio I, Naranjo-Escobar J, López D, Bedoya-Joaqui V, Nieto-Aristizábal I, Castro AM, Díaz-Ordoñez L, Navarro EP, Barrera MC, Echeverri A, Cañas CA, Tobón GJ. Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers. J Transl Autoimmun 2020;3:100027. [PMID: 32743512 DOI: 10.1016/j.jtauto.2019.100027] [Reference Citation Analysis]
184 Liu Y, Chen H, Chen Z, Qiu J, Pang H, Zhou Z. Novel Roles of the Tim Family in Immune Regulation and Autoimmune Diseases. Front Immunol 2021;12:748787. [PMID: 34603337 DOI: 10.3389/fimmu.2021.748787] [Reference Citation Analysis]
185 Oliva-Damaso N, Payan J, Oliva-Damaso E, Pereda T, Bomback AS. Lupus Podocytopathy: An Overview. Adv Chronic Kidney Dis 2019;26:369-75. [PMID: 31733721 DOI: 10.1053/j.ackd.2019.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
186 Lelios I, Cansever D, Utz SG, Mildenberger W, Stifter SA, Greter M. Emerging roles of IL-34 in health and disease. J Exp Med 2020;217:e20190290. [PMID: 31940023 DOI: 10.1084/jem.20190290] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]